We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Estimating Volume Using LiDCO
Updated: 1/20/2016
Estimating Volume Using LiDCO Versus Other Measures of Volume
Status: Enrolling
Updated: 1/20/2016
Estimating Volume Using LiDCO
Updated: 1/20/2016
Estimating Volume Using LiDCO Versus Other Measures of Volume
Status: Enrolling
Updated: 1/20/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Updated: 1/21/2016
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia
Updated: 1/21/2016
Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Updated: 1/21/2016
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Status: Enrolling
Updated: 1/21/2016
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Updated: 1/21/2016
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Updated: 1/21/2016
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Status: Enrolling
Updated: 1/21/2016
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Updated: 1/21/2016
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Updated: 1/22/2016
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Click here to add this to my saved trials